TD Cowen Starts Jasper Therapeutics (JSPR) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Jasper Therapeutics (JSPR) Announces Additional Positive Data from Phase 1b/2a of briquilimab
March 15, 2024 8:01 AM EDTJasper Therapeutics, Inc. (Nasdaq: JSPR) announced additional positive Phase 1b/2a data on briquilimab as a conditioning agent in the treatment of Fanconi Anemia (FA).
The data was presented at the 2024 Stanford Medicine Center for Definitive and Curative Medicine Symposium on March 13,... More
